Treatment of antibody-mediated rejection after kidney transplantation.
Sureshkumar
K K
KK
Division of Nephrology and Hypertension, Allegheny General Hospital, Pittsburgh, Pennsylvania 15252, USA. ksureshk@wpahs.org
Oti
I U
IU
Baroody
S C
SC
Hussain
S M
SM
Carpenter
B J
BJ
Nghiem
D D
DD
Marcus
R J
RJ
D000328:Adult; D000906:Antibodies / Q000276:immunology*; D015703:Antigens, CD / Q000032:analysis; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D019013:CD40 Antigens / Q000032:analysis; D005260:Female; D006084:Graft Rejection / Q000276:immunology / Q000517:prevention & control / Q000628:therapy*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000276:immunology* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D014184:Transplantation, Homologous / Q000276:immunology / Q000473:pathology
D000906:Antibodies; D015703:Antigens, CD; D000961:Antilymphocyte Serum; D019013:CD40 Antigens; D007166:Immunosuppressive Agents